
Auteur M. VENTURA
|
Documents disponibles écrits par cet auteur (7)

P. E. OOMEN ; D. SCHORI ; K. TOGEL-LINS ; D. ACREMAN ; S. CHENORHOKIAN ; A. LUF ; A. KARDEN ; C. PAULOS ; E. FORNERO ; E. GERACE ; R. P. J. KONING ; L. GALINDO ; L. A. SMIT-RIGTER ; F. MEASHAM ; M. VENTURA | 2022
Dans International Journal of Drug Policy (Vol.100, February 2022) Article : PériodiqueBackground: European drug checking services exchange information on drug trends within the Trans European Drug Information (TEDI) network, allowing monitoring and coordination of responses. Starting in Spring 2020, several services detected the [...]
N. VAN DER LINDEN ; R. P. J. KONING ; D. VAN DER GOUWE ; M. VENTURA ; F. MEASHAM | 2022
Dans Drugs, Habits and Social Policy (Vol.23, n°3, 2022) Article : PériodiquePurpose: The purpose of this paper is to present some of the continued resistance and challenges faced by drug checking services (DCS) and review how the existing literature and the contributions to the special issue address them, with a view to[...]
L. CONEY ; A. PEACOCK ; D. VAN DER GOUWE ; L. SMIT-RIGTER ; N. HUTTEN ; M. VENTURA ; A. QUESADA ; M. J. BARRATT | 2025
Dans Addiction (Vol.120, n°1, January 2025) Article : PériodiqueBACKGROUND AND AIMS: Drugs sold on cryptomarkets are thought to have lower levels of adulteration and higher strength compared with those sourced off-line. The present study aimed to determine whether cryptomarket and off-line-sourced 3,4-methyl[...]
This publication, part of Correlation - European Harm Reduction Network's Civil Society-led Monitoring of Harm Reduction in Europe 2024 Data Report, examines key findings from drug checking services across Europe over the past years. It provides[...]
S. PICHINI ; M. VENTURA ; M. PUJADAS ; R. VENTURA ; R. DI GIOVANNANDREA ; P. ZUCCARO ; R. PACIFICI ; R. DE LA TORRE ; C. JURADO | 2005
Dans Annales de Toxicologie Analytique (Vol.17, n°4, 2005) Article : PériodiqueComparaison des méthodes de dépistage de stupéfiants dans les cheveux, d'un point de vue qualitatif et quantitatif, de deux groupes de laboratoires (Italian National Health Service et Sociey of Hair Testing).Nouveauté
F. CAUDEVILLA ; M. VENTURA ; I. FORNIS ; M. J. BARRATT ; C. VIDAL ; C. G. LLADANOSA ; P. QUINTANA ; A. MUNOZ ; N. CALZADA | 2016
Dans International Journal of Drug Policy (Vol.35, September 2016) Article : PériodiqueIntroduction: User surveys indicate that expectations of higher drug purity are a key reason for cryptomarket use. In 2014-2015, Spain's NGO Energy Control conducted a 1-year pilot project to provide a testing service to cryptomarket drug users [...]
R. Q. VROLIJK ; F. MEASHAM ; A. QUESADA ; A. LUF ; D. SCHORI ; S. RADLEY ; D. ACREMAN ; J. SMITH ; M. VERDENIK ; D. MARTINS ; M. CUNHA ; C. J. PAULOS ; I. F. PICCININ ; E. GERACE ; A. KARDEN ; R. P. J. KONING ; L. A. SMIT-RIGTER ; M. VENTURA | 2022
Dans Drugs, Habits and Social Policy (Vol.23, n°3, 2022) Article : PériodiquePurpose: The 3,4-methylenedioxymetamphetamine (MDMA) content in ecstasy tablets has increased enormously throughout Europe across the past decade. This study aims to determine whether this is caused by the production of "stronger" tablets (more [...]